Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 740

Results For "AI"

8320 News Found

Clinical study shows ViroStop spray prevents Covid-19
News | November 11, 2021

Clinical study shows ViroStop spray prevents Covid-19

Evidence also shows better immune response to virus among users of spray


LifeCell Diagnostics expands newborn screening portfolio
Clinical Trials | November 11, 2021

LifeCell Diagnostics expands newborn screening portfolio

LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns


Medtronic first to launch cryoballoon catheter in India
Medical Device | November 10, 2021

Medtronic first to launch cryoballoon catheter in India

Cryoballoon catheter ablation, a minimally invasive procedure, is one of the therapeutic modalities to manage Atrial fibrillation


IVD system to assist assay developers and clinical labs for molecular diagnostics
Medical Device | November 10, 2021

IVD system to assist assay developers and clinical labs for molecular diagnostics

Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow


Moderna seeks approval from EMA for its Covid-19 vaccine for children between 6-11 years
News | November 10, 2021

Moderna seeks approval from EMA for its Covid-19 vaccine for children between 6-11 years

The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11


US govt places additional order of 1.4 million courses of molnupiravir
News | November 10, 2021

US govt places additional order of 1.4 million courses of molnupiravir

Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults


Pulmatrix resolves dispute with Cipla
News | November 10, 2021

Pulmatrix resolves dispute with Cipla

Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.


India Pharmaceutical Market grows 5% in October 2021
News | November 10, 2021

India Pharmaceutical Market grows 5% in October 2021

Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22


AstraZeneca Pharma India PAT at Rs 11.94 cr. in Q2FY22
News | November 10, 2021

AstraZeneca Pharma India PAT at Rs 11.94 cr. in Q2FY22

The Board of Directors of AstraZeneca Pharma India have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021


Zydus Cadila receives approval for glycopyrrolate injection
Drug Approval | November 10, 2021

Zydus Cadila receives approval for glycopyrrolate injection

Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated